Watch Your Diabetic Medications

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database — Tzoulaki et al. 339: b4731 — BMJ

Conclusions Our findings suggest a relatively unfavourable risk profile of sulphonylureas compared with metformin for all outcomes examined. Pioglitazone was associated with reduced all cause mortality compared with metformin. Pioglitazone also had a favourable risk profile compared with rosiglitazone; although this requires replication in other studies, it may have implications for prescribing within this class of drugs.

Walk Faster Live Longer

I think I’ll go for a walk.

Medical News: Walking Speed Predicts CV Death in Seniors – in Primary Care, Geriatrics from MedPage Today

The slowest walkers among those over 65 were 44% more likely to die of any cause over a five-year period than faster walkers, Alexis Elbaz, MD, PhD, of the University Pierre and Marie Curie in Paris, and colleagues reported online in BMJ.